4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-18-000993
Chief Executive Officer gave up 42,335 shares (to pay taxes)
- Chief Executive Officer acquired 348,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2017-12-29 | Grant or award | +348,000 | 1,431,731 | D | ||
| Cooper Laurence James Neil Chief Executive Officer | 2017-12-30 | Shares withheld for taxes | −26,178 | $4.14 | $108,377 | 1,405,553 | D |
| Cooper Laurence James Neil Chief Executive Officer | 2017-12-31 | Shares withheld for taxes | −16,157 | $4.14 | $66,890 | 1,389,396 | D |
Loading xslF345X03/doc4.xml…